Cinacalcet is a calcimimetic agent that functions by sensitizing calcium-sensing receptors to decrease parathyroid hormone secretion, primarily indicated for the treatment of secondary hyperparathyroidism… Read more
















































Cinacalcet is a calcimimetic agent that functions by sensitizing calcium-sensing receptors to decrease parathyroid hormone secretion, primarily indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and for managing hypercalcemia in cases of parathyroid carcinoma. This category provides an extensive collection of Cinacalcet reference standards, including the active enantiomer, racemic forms, and a comprehensive range of process-related impurities, degradation products, and stable isotope labelled compounds. These high-quality materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, method validation, and quality control. Laboratories utilize these standards for critical procedures such as impurity profiling, genotoxicity screening, and forced degradation studies to ensure the safety and efficacy of the drug substance. By providing access to pharmacopeial and non-pharmacopeial related compounds, this collection supports precise identification and quantification throughout the drug development and manufacturing lifecycle, facilitating compliance with international regulatory standards.